112 related articles for article (PubMed ID: 25488994)
1. Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barré syndrome.
Miyaji K; Devaux J; Yuki N
Neurology; 2014 Dec; 83(24):2314. PubMed ID: 25488994
[No Abstract] [Full Text] [Related]
2. Author response.
Sawai S; Mori M; Kuwabara S
Neurology; 2014 Dec; 83(24):2314; discussion 2314-5. PubMed ID: 25632420
[No Abstract] [Full Text] [Related]
3. Ranvier revisited: novel nodal antigens stimulate interest in GBS pathogenesis.
Willison H; Scherer SS
Neurology; 2014 Jul; 83(2):106-8. PubMed ID: 24920859
[No Abstract] [Full Text] [Related]
4. Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barré syndrome.
Sawai S; Satoh M; Mori M; Misawa S; Sogawa K; Kazami T; Ishibashi M; Beppu M; Shibuya K; Ishige T; Sekiguchi Y; Noda K; Sato K; Matsushita K; Kodera Y; Nomura F; Kuwabara S
Neurology; 2014 Jul; 83(2):113-7. PubMed ID: 24920858
[TBL] [Abstract][Full Text] [Related]
5. Role of gancyclovir and HAART administration in the treatment of a rare complication of HIV disease: cytomegalovirus-associated Guillain-Barré syndrome.
Calza L; Manfredi R; Marinacci G; Briganti E; Giuliani R; Talo S; Chiodo F
J Chemother; 2001 Oct; 13(5):575-7. PubMed ID: 11760224
[TBL] [Abstract][Full Text] [Related]
6. [Guillain-Barré syndrome following cytomegalovirus infection with increased level of antibody against moesin-a case report].
Shiga Y; Shimoe Y; Chigusa M; Kusunoki S; Mori M; Kuriyama M
Rinsho Shinkeigaku; 2018 Jun; 58(6):385-389. PubMed ID: 29863101
[TBL] [Abstract][Full Text] [Related]
7. Guillain-Barré syndrome with optic neuritis and cytomegalovirus infection.
Igarashi O; Fujioka T; Kishi M; Normoto N; Iwasaki Y; Kurihara T
J Peripher Nerv Syst; 2005 Sep; 10(3):340-1. PubMed ID: 16221294
[No Abstract] [Full Text] [Related]
8. CMV-associated axonal sensory-motor Guillain-Barré syndrome in a child: Case report and review of the literature.
Spagnoli C; Iodice A; Salerno GG; Frattini D; Bertani G; Pisani F; Fusco C
Eur J Paediatr Neurol; 2016 Jan; 20(1):168-75. PubMed ID: 26621312
[TBL] [Abstract][Full Text] [Related]
9. [A case of Guillain-Barré Syndrome complicated with Fat Embolism syndrome].
Edanaga M; Arakawa J; Kobayashi I; Fujimura N; Namiki A
Masui; 2003 May; 52(5):530-3. PubMed ID: 12795139
[TBL] [Abstract][Full Text] [Related]
10. [Guillain-Barré syndrome associated with cytomegalovirus infection after kidney transplantation].
Lloveras JJ; Larrue V; Delisle MB; Tack I; Icart J; Dupré C; Ton That H; Durand D; Suc JM
Presse Med; 1994 Jun; 23(21):976-8. PubMed ID: 7937644
[TBL] [Abstract][Full Text] [Related]
11. [Guillain-Barré syndrome in kidney transplant].
García Alvarez T; García Herrera A; Mazuecos Blanca A; Lancho Novillo C
Nefrologia; 2010; 30(2):260-1. PubMed ID: 20393626
[No Abstract] [Full Text] [Related]
12. Improvement of cytomegalovirus-related Guillain-Barré syndrome after high doses of intravenous methylprednisolone pulses.
Beauvais K; Furby A
Eur Neurol; 2006; 56(1):41-3. PubMed ID: 16921241
[No Abstract] [Full Text] [Related]
13. HLA-G expression in Guillain-Barré syndrome is associated with primary infection with cytomegalovirus.
Pangault C; Le Tulzo Y; Minjolle S; Le Page E; Sebti Y; Guilloux V; Fauchet R; Amiot L
Viral Immunol; 2004; 17(1):123-5. PubMed ID: 15018669
[No Abstract] [Full Text] [Related]
14. Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies?
Miyaji K; Shahrizaila N; Umapathi T; Chan YC; Hirata K; Yuki N
Hum Immunol; 2014 Nov; 75(11):1089-91. PubMed ID: 25286001
[TBL] [Abstract][Full Text] [Related]
15. Guillain-Barré syndrome following primary cytomegalovirus infection: a prospective cohort study.
Orlikowski D; Porcher R; Sivadon-Tardy V; Quincampoix JC; Raphaël JC; Durand MC; Sharshar T; Roussi J; Caudie C; Annane D; Rozenberg F; Leruez-Ville M; Gaillard JL; Gault E
Clin Infect Dis; 2011 Apr; 52(7):837-44. PubMed ID: 21427390
[TBL] [Abstract][Full Text] [Related]
16. Late-onset cytomegalovirus infection complicated by Guillain-Barre syndrome in a kidney transplant recipient: case report and review of the literature.
Shaban E; Gohh R; Knoll BM
Infection; 2016 Apr; 44(2):255-8. PubMed ID: 26141820
[TBL] [Abstract][Full Text] [Related]
17. Guillain-Barré syndrome associated with resistant cytomegalovirus infection after face transplantation.
Alhefzi M; Aycart MA; Bueno EM; Kueckelhaus M; Fischer S; Snook RJ; Sharfuddin AA; Hadad I; Malla P; Amato AA; Pomahac B; Marty FM
Transpl Infect Dis; 2016 Apr; 18(2):288-92. PubMed ID: 26910286
[TBL] [Abstract][Full Text] [Related]
18. The relationship between cytomegalovirus infection and Guillain-Barré syndrome.
Lunn M; Hughes R
Clin Infect Dis; 2011 Apr; 52(7):845-7. PubMed ID: 21427391
[No Abstract] [Full Text] [Related]
19. Guillain-Barré syndrome and cytomegalovirus infection during pregnancy.
Lupo J; Germi R; Jean D; Baccard-Longère M; Casez O; Besson G; Rougé A; Boutonnat J; Schwebel C; Hoffmann P; Morand P
J Clin Virol; 2016 Jun; 79():74-76. PubMed ID: 27105316
[TBL] [Abstract][Full Text] [Related]
20. [Target Molecule for a Demyelinating Type of Guillain-Barré Syndrome, Acute Inflammatory Demyelinating Polyneuropathy].
Mori M
Brain Nerve; 2015 Nov; 67(11):1359-69. PubMed ID: 26560951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
